Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v6-FR
Language French French
Date Updated 2017-07-04 2017-04-03
Drug Identification Number 00755575 00755575
Brand name MODECATE CONCENTRATE MODECATE CONCENTRATE
Common or Proper name Fluphenazine Decanoate Fluphenazine Decanoate
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients FLUPHENAZINE DECANOATE FLUPHENAZINE DECANOATE
Strength(s) 100mg 100mg
Dosage form(s) Liquid Liquid
Route of administration IV IV
Packaging size 5amp x 1ml 5amp x 1ml
ATC code N05AB N05AB
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2017-05-31 2017-05-31
Actual start date
Estimated end date 2017-06-30
Actual end date 2017-05-19
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Stock is available. No supply issues at this time. Supply is on allocation. Please contact your preferred wholesaler/distributor for availability.
Health Canada comments